SomedebBallMD(He/Him)

PubMed

• 25 citations
  Platelets in chronic obstructive pulmonary disease: An update on pathophysiology and implications for antiplatelet therapy.
  Haneen Mallah, Somedeb Ball, Jasmine Sekhon, Kanak Parmar, Kenneth Nugent
  Respiratory Medicine. 2020-09-01
• 110 citations
  Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week
  Somedeb Ball, Raktim K. Ghosh, Sariya Wongsaengsak, Dhrubajyoti Bandyopadhyay, Gopal Chandra Ghosh
  Journal of the American College of Cardiology. 2019-10-01
• 42 citations
  Dysautonomia: An Overlooked Neurological Manifestation in a Critically ill COVID-19 Patient.
  Nouran Eshak, Mahmoud Abdelnabi, Somedeb Ball, Emaneldeen Elgwairi, Kendall Creed
  The American Journal of the Medical Sciences. 2020-01-01

Journal Articles

• Canakinumab: Promises and Future in Cardiometabolic Diseases and Malignancy  
  Somedeb Ball, MD, The American Journal of Medicine

Abstracts/Posters

• Performance of the New Automated Latex Immunoturbidometric Assay in the Diagnosis of Heparin Induced Thrombocytopenia: A Single Institution Experience
  Somedeb Ball, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Efficacy of Upfront Daratumumab Combination Regimen in Patients with Newly Diagnosed Multiple Myeloma
  Somedeb Ball, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Risk of Serious Infections with Carfilzomib in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Effective Implementation of a Structured Protocol for Facilitation of the Judicious Use of Antibody Test for Diagnosis of Heparin Induced Thrombocytopenia 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Thrombotic episodes in myeloproliferative neoplasms: A population based study. 
  2019 ASCO Annual Meeting - 6/1/2019
• Risk of Atrial Fibrillation with Ibrutinib in Patients with B-Cell Malignancies: An Updated Meta-Analysis of Phase III Randomized Controlled Trials 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Risk of Atrial Fibrillation with Ibrutinib in Patients with B-Cell Malignancies: An Updated Meta-Analysis of Phase III Randomized Controlled Trials 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all